ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RTGN Retinalgenix Technologies Inc (QB)

3.50
0.00 (0.00%)
25 Jun 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Assets 5k00
Total Current Assets 5k00
Cash and Equivalents 5k00
Total Non-Current Assets -465k-1.07M-1.41M
Total Liabilities 470k1.07M1.41M
Total Current Liabilities 470k1.07M1.41M
Total Non-Current Liabilities 000
Total Equity -465k-1.07M-1.41M
Common Equity 1,0002k2k
Retained Earnings -5.1M-9.02M-11.11M